Alcon Gets FDA Approval for Travatan-Z Which Reduce Elevated Intraocular Pressure

Alcon Inc. (ACL) received Food and Drug Administration approval for Travatan Z for the reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension.

Travatan Z is a new formulation that eliminates benzalkonium chloride from Alcon's existing Travatan solution and replaces BAK with Sofzia, a robust ionic buffered preservative system that is gentle to the ocular surface, the eye-care company said.

Link [online.wsj.com/article/BT-CO-20060921-715891.html?mod=wsjcrmain]

Related?

2 Responses to “Alcon Gets FDA Approval for Travatan-Z Which Reduce Elevated Intraocular Pressure”

  1. Meaghan D'Otazzo Says:

    I’m using since about 10 weeks Travatan Z to reduce ocular pressure on my left eye and after 8 days I noticed that my luxurius thick hair was getting thinner and was losing hair. Went to my dermatologist and had test where the keratin, sebum. estrogen etc .. were normal and my Internist suggested that if I was on Travatan Z, Sofzia the the ionic element causes 85% of the time loss of hair. He had some patients with the same problem that are/were on Travatan Z.

  2. Trudi Kessler Says:

    Worst than that happened to my mother. It was presctiberd by Dr. Samer Ahmed who was with the Wilmer Institute until he was not reinstated again due to “problems” with patients.

Leave a Reply


Protected by Comment Guard Pro